Camille P Figueiredo1, Mariana O Perez2, Lucas Peixoto Sales2, Ana Cristina Medeiros3, Valeria F Caparbo2, Rosa M R Pereira4,5. 1. Bone Metabolism Laboratory, Rheumatology Division, Faculdade de Medicina FMUSP Universidade de Sao Paulo, Av. Dr. Arnaldo 455, 3° andar, sala 3105, Sao Paulo, 01246-903, Brazil. figueiredocamille@gmail.com. 2. Bone Metabolism Laboratory, Rheumatology Division, Faculdade de Medicina FMUSP Universidade de Sao Paulo, Av. Dr. Arnaldo 455, 3° andar, sala 3105, Sao Paulo, 01246-903, Brazil. 3. Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina FMUSP Universidade de Sao Paulo, Sao Paulo, SP, Brazil. 4. Bone Metabolism Laboratory, Rheumatology Division, Faculdade de Medicina FMUSP Universidade de Sao Paulo, Av. Dr. Arnaldo 455, 3° andar, sala 3105, Sao Paulo, 01246-903, Brazil. rosamariarp@yahoo.com. 5. Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina FMUSP Universidade de Sao Paulo, Sao Paulo, SP, Brazil. rosamariarp@yahoo.com.
Abstract
BACKGROUND: Rheumatoid arthritis (RA) is a chronic autoimmune disease depicted by synovial inflammation leading to local and systemic bone loss. The aim of this study was to evaluate by a HR-pQCT (High Resolution Peripheral Quantitative Computed Tomography) study which parameters are associated with volume of bone erosions including bone mineral density (BMD) around erosions (VOI 1 to 4 = volume of interest), BMD of metacarpophalangeal (MCP) head, BMD of radius, presence of osteophytes and joint space width (JSW). METHODS: Fifty female RA patients (18-50 years) were enrolled in this study. Demographic and disease-specific data, laboratory inflammatory parameters and handgrip test were performed. All patients underwent HR-pQCT of 2nd and 3rd MCP joints and distal radius, according to established protocols. The volume of bone erosions was evaluated by MIAF (Medical Image Analysis Framework) software. Osteophytes were analyzed by manual method. RESULTS: The mean of age and disease duration were 40.0 ± 6.0 yrs. and 10.8 ± 4.8 yrs., respectively. According to DAS-28 (Disease Activity Score), 54% (27) of the sample were in remission. However, when SDAI (Simplified Disease Activity Index) was used, only 18% (9) were under remission. The mean of HAQ (Health Assessment Questionnaire), ESR (Erythrocyte sedimentation rate) and CRP (C reactive protein) were 0.9 ± 0.7, 13.9 ± 12.2 mm and 5.6 ± 7.5 mg/mL, respectively. Forty-six bone erosions (0.9 ± 1.2 erosion/patient) and 14 osteophytes (0.3 ± 0.7 osteophyte/patient) were found in 2nd MCP head. The median (IQR-Interquartile range) of volume of erosion and volume of osteophytes were 14.9 (5.7;35.9)mm3 and 3.1 (2.1, 4.3)mm3, respectively. The mean of JSW was 80.5 ± 34.2 mm3. The volume of bone erosions was negatively correlated with BMD of 2nd MCP head, VOI-4 and JSW; and it was positively correlated with osteophytes number. Regarding absence or presence of erosion in 2nd MCP head, a significant difference was found between BMD of MCP head, osteophyte number and JSW. Multiple linear regression analysis showed that only BMD of 2nd MCP head was independently associated with volume of bone erosions. CONCLUSION: BMD of MCP head was independently associated with volume of bone erosion, suggesting that this parameter should be used to analyze and monitoring bone destruction, as well as to evaluate treatment response in RA patients.
BACKGROUND:Rheumatoid arthritis (RA) is a chronic autoimmune diseasedepicted by synovial inflammation leading to local and systemic bone loss. The aim of this study was to evaluate by a HR-pQCT (High Resolution Peripheral Quantitative Computed Tomography) study which parameters are associated with volume of bone erosions including bone mineral density (BMD) around erosions (VOI 1 to 4 = volume of interest), BMD of metacarpophalangeal (MCP) head, BMD of radius, presence of osteophytes and joint space width (JSW). METHODS: Fifty female RApatients (18-50 years) were enrolled in this study. Demographic and disease-specific data, laboratory inflammatory parameters and handgrip test were performed. All patients underwent HR-pQCT of 2nd and 3rd MCP joints and distal radius, according to established protocols. The volume of bone erosions was evaluated by MIAF (Medical Image Analysis Framework) software. Osteophytes were analyzed by manual method. RESULTS: The mean of age and disease duration were 40.0 ± 6.0 yrs. and 10.8 ± 4.8 yrs., respectively. According to DAS-28 (Disease Activity Score), 54% (27) of the sample were in remission. However, when SDAI (Simplified Disease Activity Index) was used, only 18% (9) were under remission. The mean of HAQ (Health Assessment Questionnaire), ESR (Erythrocyte sedimentation rate) and CRP (C reactive protein) were 0.9 ± 0.7, 13.9 ± 12.2 mm and 5.6 ± 7.5 mg/mL, respectively. Forty-six bone erosions (0.9 ± 1.2 erosion/patient) and 14 osteophytes (0.3 ± 0.7 osteophyte/patient) were found in 2nd MCP head. The median (IQR-Interquartile range) of volume of erosion and volume of osteophytes were 14.9 (5.7;35.9)mm3 and 3.1 (2.1, 4.3)mm3, respectively. The mean of JSW was 80.5 ± 34.2 mm3. The volume of bone erosions was negatively correlated with BMD of 2nd MCP head, VOI-4 and JSW; and it was positively correlated with osteophytes number. Regarding absence or presence of erosion in 2nd MCP head, a significant difference was found between BMD of MCP head, osteophyte number and JSW. Multiple linear regression analysis showed that only BMD of 2nd MCP head was independently associated with volume of bone erosions. CONCLUSION: BMD of MCP head was independently associated with volume of bone erosion, suggesting that this parameter should be used to analyze and monitoring bone destruction, as well as to evaluate treatment response in RApatients.
Entities:
Keywords:
Bone erosions; HR-pQCT; Periarticular bone loss
Authors: K P Machold; T A Stamm; V P K Nell; S Pflugbeil; D Aletaha; G Steiner; M Uffmann; J S Smolen Journal: Rheumatology (Oxford) Date: 2006-08-09 Impact factor: 7.580
Authors: Camille P Figueiredo; Arnd Kleyer; David Simon; Fabian Stemmler; Isabelle d'Oliveira; Anja Weissenfels; Oleg Museyko; Andreas Friedberger; Axel J Hueber; Judith Haschka; Matthias Englbrecht; Rosa M R Pereira; Juergen Rech; Georg Schett; Klaus Engelke Journal: Semin Arthritis Rheum Date: 2017-09-23 Impact factor: 5.532
Authors: L M Jansen; I E van der Horst-Bruinsma; D van Schaardenburg; P D Bezemer; B A Dijkmans Journal: Ann Rheum Dis Date: 2001-10 Impact factor: 19.103
Authors: Christian M Stach; Michael Bäuerle; Matthias Englbrecht; Gerhard Kronke; Klaus Engelke; Bernhard Manger; Georg Schett Journal: Arthritis Rheum Date: 2010-02
Authors: Andreas Albrecht; Stephanie Finzel; Matthias Englbrecht; Jürgen Rech; Axel Hueber; Philipp Schlechtweg; Michael Uder; Georg Schett Journal: Ann Rheum Dis Date: 2012-09-19 Impact factor: 19.103
Authors: David Simon; Arnd Kleyer; Fabian Stemmler; Christoph Simon; Andreas Berlin; Axel J Hueber; Judith Haschka; Nina Renner; Camille Figueiredo; Winfried Neuhuber; Thomas Buder; Matthias Englbrecht; Juergen Rech; Klaus Engelke; Georg Schett Journal: J Bone Miner Res Date: 2016-11-18 Impact factor: 6.741
Authors: Stephen R Pye; Judith E Adams; Kate A Ward; Diane K Bunn; Deborah P M Symmons; Terence W O'Neill Journal: Rheumatology (Oxford) Date: 2010-06-23 Impact factor: 7.580